These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34401872)

  • 1. Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21.
    Head Zauche L; Wallace B; Smoots AN; Olson CK; Oduyebo T; Kim SY; Peterson EE; Ju J; Beauregard J; Wilcox AJ; Rose CE; Meaney-Delman D; Ellington SR
    Res Sq; 2021 Aug; ():. PubMed ID: 34401872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA COVID-19 vaccination early in pregnancy and the risk of spontaneous abortion in an international pregnancy registry.
    Mansour O; Hernandez-Diaz S; Wyszynski DF
    Pharmacoepidemiol Drug Saf; 2023 Jun; 32(6):685-693. PubMed ID: 36750979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccination in pregnancy: early experience from a single institution.
    Trostle ME; Limaye MA; Avtushka V; Lighter JL; Penfield CA; Roman AS
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100464. PubMed ID: 34411758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Booster Vaccination in Early Pregnancy and Surveillance for Spontaneous Abortion.
    Kharbanda EO; Haapala J; Lipkind HS; DeSilva MB; Zhu J; Vesco KK; Daley MF; Donahue JG; Getahun D; Hambidge SJ; Irving SA; Klein NP; Nelson JC; Weintraub ES; Williams JTB; Vazquez-Benitez G
    JAMA Netw Open; 2023 May; 6(5):e2314350. PubMed ID: 37204791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
    Lipkind HS; Vazquez-Benitez G; DeSilva M; Vesco KK; Ackerman-Banks C; Zhu J; Boyce TG; Daley MF; Fuller CC; Getahun D; Irving SA; Jackson LA; Williams JTB; Zerbo O; McNeil MM; Olson CK; Weintraub E; Kharbanda EO
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(1):26-30. PubMed ID: 34990445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: a population-based study in Taiwan.
    Huang WT; Tang FW; Yang SE; Chih YC; Chuang JH
    Vaccine; 2014 Nov; 32(48):6463-8. PubMed ID: 25285884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.
    Kharbanda EO; Vazquez-Benitez G; DeSilva MB; Naleway AL; Klein NP; Hechter RC; Glanz JM; Donahue JG; Jackson LA; Sheth SS; Greenberg V; Panagiotakopoulos L; Mba-Jonas A; Lipkind HS
    JAMA Netw Open; 2021 Apr; 4(4):e214340. PubMed ID: 33818618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response.
    Myers TR; Marquez PL; Gee JM; Hause AM; Panagiotakopoulos L; Zhang B; McCullum I; Licata C; Olson CK; Rahman S; Kennedy SB; Cardozo M; Patel CR; Maxwell L; Kallman JR; Shay DK; Shimabukuro TT
    Vaccine; 2023 Feb; 41(7):1310-1318. PubMed ID: 36697313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
    Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
    Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
    JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the safety of COVID-19 vaccines in pregnancy in the US.
    Moro PL; Panagiotakopoulos L; Oduyebo T; Olson CK; Myers T
    Hum Vaccin Immunother; 2021 Dec; 17(12):4705-4713. PubMed ID: 34756131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 mRNA vaccine in pregnancy: Results of the Swiss COVI-PREG registry, an observational prospective cohort study.
    Favre G; Maisonneuve E; Pomar L; Winterfeld U; Daire C; Martinez de Tejada B; Delecraz D; Campelo S; Moser M; Todesco-Bernasconi M; Sturm S; Hösli I; Monod C; Frey Tirri B; Kalimeris S; Blume C; Mathis J; Zimmerman R; Radan AP; Surbek D; Baud D; Panchaud A
    Lancet Reg Health Eur; 2022 Jul; 18():100410. PubMed ID: 35651954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) network cohort study.
    Sadarangani M; Soe P; Shulha HP; Valiquette L; Vanderkooi OG; Kellner JD; Muller MP; Top KA; Isenor JE; McGeer A; Irvine M; De Serres G; Marty K; Bettinger JA;
    Lancet Infect Dis; 2022 Nov; 22(11):1553-1564. PubMed ID: 35964614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
    Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
    Chapin-Bardales J; Myers T; Gee J; Shay DK; Marquez P; Baggs J; Zhang B; Licata C; Shimabukuro TT
    Vaccine; 2021 Nov; 39(48):7066-7073. PubMed ID: 34763946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
    Moro PL; Olson CK; Clark E; Marquez P; Strid P; Ellington S; Zhang B; Mba-Jonas A; Alimchandani M; Cragan J; Moore C
    Vaccine; 2022 May; 40(24):3389-3394. PubMed ID: 35489985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study.
    Crowe HM; Wesselink AK; Wise LA; Jick SS; Rothman KJ; Mikkelsen EM; Sørensen HT; Hatch EE
    J Headache Pain; 2022 Dec; 23(1):162. PubMed ID: 36539705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
    Hause AM; Baggs J; Marquez P; Abara WE; Baumblatt JG; Thompson D; Su JR; Myers TR; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(28):899-903. PubMed ID: 35834416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.